The use of polyvinyl chloride (PVC or vinyl) in healthcare applications is governed by numerous regulations and standards in Europe. These frameworks ensure that vinyl-based medical products meet strict safety, quality, and environmental requirements. This page provides an overview of key European regulations impacting PVC in medical devices and pharmaceutical packaging. It is not exhaustive and should be supplemented with official regulatory texts and industry guidance.
PVC in Medical Devices
Medical Device Regulation (MDR) – (EU) 2017/745
Governs medical devices in the EU, including those made from PVC.
Specific Justification required:
- Medical devices containing DEHP (or other CMR 1A/1B and endocrine-disrupting substances) above 0.1% w/w must undergo a benefit-risk assessment, considering:
-
-
- Exposure risks to patients and users.
- Availability of safer alternatives.
- Justification for continued use based on performance and safety.
-
Deadlines for CE Marking of Legacy Devices:
-
-
- 31 December 2027 for high-risk devices.
- 31 December 2028 for low- and medium-risk devices.
-
Applies to: Blood bags, medical tubing, catheters, surgical and patient safety supplies, and diagnostic/treatment equipment.
In Vitro Diagnostic Medical Devices Regulation – (EU) 2017/746
Governs in vitro diagnostic (IVD) medical devices in the EU, including those made from vinyl.
Specific Justification Required:
- In vitro diagnostic devices containing DEHP (or other CMR 1A/1B and endocrine-disrupting substances) above 0.1% w/w must undergo a benefit-risk assessment, considering:
- Exposure risks to patients and users.
- Availability of safer alternatives.
- Justification for continued use based on performance and safety.
Deadlines for CE Marking of Legacy Devices:
- 26 May 2025 – Deadline for high-risk IVD devices (Class D).
- 26 May 2026 – Deadline for medium-risk IVD devices (Class C).
- 26 May 2027 – Deadline for low-risk IVD devices (Class B).
- 26 May 2028 – Deadline for Class A sterile devices.
Applies to:
- Diagnostic equipment (e.g., fluid-handling systems, reagent reservoirs, blood collection tubes).
- IVD consumables (e.g., diagnostic test cartridges, sample transport materials).
- Medical laboratory components (e.g., PVC tubing, insulated cables in IVD devices).
REACH Regulation – (EC) No 1907/2006
Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) regulates substances used in PVC medical applications.
Key Compliance Requirements:
- Monomer (VCM) registration required.
- Polymer (PVC resin) itself is not subject to registration, but additives (plasticisers, stabilisers etc.) must comply.
- Annex XIV – Authorisation List:
- DEHP, BBP, DBP, and DIBP are authorisation-listed due to endocrine-disrupting properties.
- Latest application date for DEHP authorisation: 1 January 2029.
- Sunset date: 1 July 2030 (after this, medical devices with DEHP must be authorised or withdrawn from the market).
- Annex XVII – Restrictions List:
- Lead compounds in PVC are restricted.
Applies to: Medical devices, pharmaceutical packaging, hospital infrastructure materials, emergency and rescue equipment.
RoHS Directive – (EU) 2015/863 (RoHS 3)
Restricts hazardous substances in electrical and electronic equipment (EEE), including DEHP in medical devices.
Key Dates:
- 22 July 2021 – Restriction of DEHP in medical electrical devices and cables.
- Exemptions for devices placed on the market before this date.
Applies to: PVC cables, medical device wiring, and hospital-grade electrical systems.
European Pharmacopoeia (Ph. Eur.)
Establishes quality standards for PVC in pharmaceutical and medical applications.
Key areas of compliance:
- Migration limits for plasticisers and additives in PVC medical-grade materials.
- Specific monographs on:
- Non-plasticised PVC for oral medicine containers.
- Plasticised PVC for blood bags, IV infusion bags, and tubing for transfusion sets.
- Testing and validation of packaging interactions with medicines.
Applies to: Pharmaceutical packaging (blister packs, IV bags), blood bags, and transfusion systems.
PVC in Packaging
REACH Regulation – (EC) No 1907/2006
Regulates substances used in PVC pharmaceutical packaging, ensuring compliance with restrictions on additives, including plasticisers and stabilisers.
Key Compliance Requirements:
- Annex XVII – Restrictions List:
- Lead-based stabilisers in PVC packaging are restricted.
- Certain plasticisers, including DEHP, BBP, DBP, and DIBP, are subject to authorisation due to their endocrine-disrupting properties.
- Annex XIV – Authorisation List:
- DEHP, BBP, DBP, and DIBP require authorisation for continued use in pharmaceutical applications.
Applies to: Pharmaceutical packaging (blister packs, IV bags, sterile medicine containers).
European Pharmacopoeia (Ph. Eur.)
Establishes quality and safety standards for materials used in pharmaceutical and medical applications, including PVC-based pharmaceutical packaging.
Key Compliance Requirements:
- Defines migration limits for plasticisers and additives in PVC blister packs, IV bags, and sterile medicine containers.
- Specifies testing protocols for leachables and extractables in plasticised PVC.
- Ensures that packaging materials do not release substances that could alter the quality or safety of medicines.
Relevant Monographs Cover:
- Non-plasticised PVC for solid dosage forms (e.g., tablet blister packs).
- Plasticised PVC for aqueous solutions (e.g., IV infusion bags, blood bags).
- PVC-based tubing used in pharmaceutical fluid transport and transfusion sets.
Applies to: Pharmaceutical packaging (blister packs, IV bags, sterile medicine containers), blood bags, and transfusion systems.
Good Manufacturing Practice (GMP) – Regulation (EC) No 2023/2006
Ensures high-quality production standards for pharmaceutical packaging materials, including PVC-based packaging.
Key Compliance Requirements:
- Requires strict quality control in the manufacturing, processing, and handling of PVC pharmaceutical packaging.
- Mandates testing for leachables and extractables to ensure that no harmful substances migrate from PVC packaging into pharmaceutical products.
- Ensures traceability and documentation throughout the supply chain to maintain regulatory compliance.
Applies to: Pharmaceutical packaging (blister packs, IV bags, sterile medicine containers).
Food Contact Materials Regulation – (EC) No 10/2011
Regulates plastic materials intended to come into contact with food but also applies to pharmaceutical blister packs.
Key Compliance Requirements:
- Ensures that no harmful substances migrate from PVC packaging into medicines.
- Establishes specific migration limits (SMLs) for plasticisers and additives used in PVC pharmaceutical packaging.
- Requires testing and certification to confirm compliance with safety thresholds for human exposure.
Applies to: Pharmaceutical blister packs and other PVC-based medicine packaging that may come into direct contact with pharmaceutical products, PVC food cling film used in hospital kitchens.
Materials and Articles in Contact with Food Regulation – (EC) No 1935/2004
Regulates food contact materials, with many requirements also applying to pharmaceutical packaging.
Key Compliance Requirements:
- Prevents harmful migration: PVC packaging must be designed to ensure that no substances migrate into medicinal products that could impair quality or pose health risks.
- Authorisation of substances: Only authorised substances may be used in PVC pharmaceutical packaging, and their migration must remain below specified safety limits.
Applies to: Pharmaceutical packaging (blister packs, IV bags, sterile medicine containers), PVC food cling film used in hospital kitchens.
Other Relevant Regulations & Frameworks
Construction Products Regulation (CPR) – (EU) No 305/2011
Regulates construction products within the EU, including PVC materials used in healthcare infrastructure.
Key Compliance Requirements:
- Establishes harmonised standards for the performance and safety of building materials, including PVC-based flooring, wall coverings, windows, doors, and pipes in healthcare settings.
- Requires CE marking to demonstrate compliance with European standards for fire resistance, durability, and sustainability.
Applies to: PVC flooring, wall coverings, windows, doors, and pipes used in hospital and healthcare facility construction.
Waste Framework Directive – (EU) 2008/98/EC
Sets the foundation for waste management and recycling, including PVC recovery in healthcare.
Key Compliance Requirements:
- Establishes the waste hierarchy, prioritising reuse and recycling over disposal.
- Encourages PVC medical waste collection and recycling initiatives, such as VinylPlus® Med, to reduce landfilling and improve circularity.
- Requires proper handling and disposal of healthcare plastics, including non-infectious PVC waste from medical devices.
Applies to: PVC medical devices, pharmaceutical packaging, and hospital infrastructure materials targeted for circular economy initiatives.
Drinking Water Directive – (EU) 2020/2184
Regulates materials that come into contact with drinking water, including PVC pipes used in hospitals and healthcare facilities.
Key Compliance Requirements:
- Ensures that materials in contact with drinking water do not release harmful substances that could compromise public health.
Sets limits for chemical migration from PVC pipes and fittings into drinking water. - Requires compliance with specific hygiene and material safety standards for pipes used in medical facilities.
Applies to: PVC pipes and fittings used in hospital drinking water supply, wastewater systems, and medical water purification infrastructure.
Occupational Exposure Limits (OELs)
Regulates exposure to hazardous substances in PVC resin production, ensuring worker safety under EU occupational safety and health (OSH) legislation.
Key Compliance Requirements:
- Sets safe exposure limits for substances used in PVC production, including vinyl chloride monomer (VCM) and additives.
- Regulated under the Chemical Agents Directive (CAD) and Carcinogens, Mutagens or Reprotoxic Substances Directive (CMRD) to protect workers from long-term health risks.
- Requires monitoring and control measures in PVC resin plants, medical device manufacturing, and waste handling, including:
- Air quality monitoring to ensure safe workplace exposure.
- Protective measures such as industrial ventilation and personal protective equipment (PPE).
- Substitution or minimisation of hazardous chemicals where feasible.
Applies to: Workers in PVC resin production (VCM exposure), medical device manufacturing, pharmaceutical packaging production, hospital waste management, and PVC recycling processes.
Supporting Industry Compliance & Engagement
VinylPlus Healthcare is committed to helping partners navigate the complex regulatory landscape surrounding PVC in medical devices and pharmaceutical packaging. Our initiatives focus on ensuring compliance, promoting best practices, and supporting industry stakeholders in adapting to evolving EU regulations and standards.
Join us to get expert support, stay ahead of regulatory developments, and help shape industry advocacy.